Drug and toxin-induced bile duct disorders (Q34113002)

31 July 2017

1 reference

title

Drug and toxin-induced bile duct disorders (English)

1 reference

31 July 2017

A P Geubel

1

1 reference

PubMed ID

11129214

31 July 2017

C L Sempoux

series ordinal

2

1 reference

31 July 2017

1 November 2000

1 reference

Journal of Gastroenterology and Hepatology

31 July 2017

1 reference

31 July 2017

15

1 reference

31 July 2017

11

1 reference

31 July 2017

1232-1238

1 reference

Reversible cholestasis with bile duct injury following azathioprine therapy. A case report

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.2369.X

Glyburide-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.2369.X

Hyperbilirubinaemia in patients treated with recombinant human interleukin-2 (rIL-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.2369.X

Prolonged cholestasis due to trimethoprim sulfamethoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.2369.X

Caustic sclerosing cholangitis. A complication of the surgical treatment of hydatid disease of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.2369.X

Granulomatous hepatitis secondary to carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.2369.X

10.1046/J.1440-1746.2000.2369.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11129214